Cipla

cipla.com · Mumbai, India

Cipla is a global pharmaceutical company that develops, manufactures, and markets generic and branded medicines across respiratory, HIV/AIDS, oncology, cardiovascular, and other therapeutic areas for patients in over 80 countries. It supplies prescription drugs, over-the-counter products, and active pharmaceutical ingredients to healthcare providers, governments, and distributors. The company generates revenue primarily through the sale of its pharmaceutical products and APIs to domestic and international markets.

Revenue
$3.0B
Employees
26,000
Founded
1935
Headquarters
Mumbai, India

What 13 Arbolus experts think of Cipla

NPS scores are highly positive overall, with 80% of responses at 9 or above and an average well above industry benchmarks. Most customers in the >1 year stage express strong satisfaction and renewal intent. A small subgroup of Influencers register lower NPS and uncertain renewal, generally linked to higher spend tiers. Adoption is strongest in mature customers, with Pilots and recent implementations reviewing favorably but less certain on renewal. Overall Customer Sentiment: Positive

Who reviewed Cipla

Total customers 13 13 current · 0 former
Reviews growth +8 in six months
Seniority of respondents
  • C-Suite 77% (10)
  • Director 15% (2)
  • Manager 8% (1)
Operations Manager C-Suite NPS 9 Undecided
Executive C-Suite NPS 10
Revenue Leader C-Suite NPS 9

Employer names and spend open once the report publishes.

Tell us when the Cipla report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

53 Net Promoter Score, from 13 scored reviews
  • Promoters 9
  • Passives 2
  • Detractors 2

Cumulative NPS by month

+0 over 6 months
  • Feb 8
  • Apr 8
  • May 8
  • Jun 8
  • Jul 8
  • Sep 8

Net Promoter Score across 2 reviews, accumulated up to each month. Category median 55 across 2 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 20%
  • Will renew 1
  • Undecided 3
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 0% 3 answers
  • Director 50% 2 answers
  • 10/10 Average score from customers who will renew
  • 7.7/10 Average score from undecided customers
  • 3/10 Average score from customers not renewing

Top alternatives

Most weighed by Cipla customers

For people who use Cipla

Do you use Cipla at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 13 customers of Cipla have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.